Skip to main content
. Author manuscript; available in PMC: 2013 Aug 2.
Published in final edited form as: Surgery. 2012 Oct 24;152(6):1068–1077. doi: 10.1016/j.surg.2012.08.021

Fig 2.

Fig 2

Effect of pasireotide (SOM230) on serum insulin (A) and glucose levels (B) in Pdx1-Cre:Men1 floxed/floxed conditional knockout mice with monthly subcutaneous injections of SOM230 (160mg/Kg/month [64mg/ml]) or PBS for four months.

*One-way repeated ANOVA was performed on data as long as there were at least 3 mice in each group (i.e., up to and including day 70)

†Indicates the occurrence of death (days 68, 74, and 82)